$FRTD news Fortitude Group, Inc. Submits Special Share

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz jr #23601
$FRTD news

Fortitude Group, Inc. Submits Special Share Issuance Certificate to Transfer Agent

ERIE, PA--(Marketwired - Apr 10, 2014) - Fortitude Group, Inc. (OTC: FRTD) announced today that on April 5, 2014, the company received 9,250,000 shares of Affinity Mediaworks Corp. (OTCQB: AFFW) and has submitted the certificate to the Affinity transfer agent to have the shares re-issued and forwarded to bona fide Fortitude shareholders of record, as of the calendar date: March 14, 2014 at 6:00pm EDT.

As previously announced, 9,250,000 shares of Affinity Mediaworks Corp., which represents approximately 14% of the to-be-issued and outstanding stock of Affinity Mediaworks, are being issued as a Special Share Issuance to bona fide shareholders of record of Fortitude Group, Inc. This issuance has been calculated that for every 92 FRTD shares beneficially owned by a Fortitude shareholder, they shall be entitled to receive 1 new additional share of Affinity Mediaworks. Affinity Mediaworks is set to invest $4,000,000 for a 45% in PRIMARQ in April 2014. Based on preliminary pro-forma numbers, while still a pre-revenue company, within 90-days of funding, PRIMARQ is projecting gross revenue of over $200 million per year. Currently, Affinity has raised the $4,000,000 necessary to complete this investment and under the terms of the funding agreement, the investment capital can only be released to
PRIMARQ upon verification that the Fortitude shareholders have received their AFFW Special Share Issuance certificates.

For shareholders that are unsure if they are on the NOBO (Non-Objecting Beneficial Owner) list or they just want to confirm that they are on the participation list, they can visit http://www.FRTDIssuance.com and input their personal information which will include their name, address, phone number, number of shares beneficially owned as of March 14, 2014 and purchase price.

The 9,250,000 shares of Affinity Mediaworks Corp. being distributed to Fortitude bona fide shareholders of record will carry registration rights and be registered in the Company's S-1(which will be filed with the SEC April 2014). The average timeline for an S-1 to be deemed effective is 90-days from the initial submission to the SEC. The first draft of the S-1 is currently being reviewed by management at this time and is expected to be filed on April 15, 2014.

Thomas J. Parilla, CEO of Fortitude stated, "Fortitude is growing at a fast pace as we move through April 2014. We are excited to have just booked our first revenue from the initial 5k VaporVites unit order and we are completing another 25k unit order which will be announced after the deposit is received. We have also just notified the public that due to unforeseen issues with our plan administrator, http://www.420cashcard.com will no longer be operating under the '420' brand and that we decided to replace the site with a more universally acceptable name Http://www.affinityblackcard.com. Through this new site we will be processing the over 7,000 card orders we received through the '420' brand. We are completing the final BETA test on the new site and anticipate its new launch on the 11th. We are still receiving submissions from the Http://www.FRTDIsuance.com site from shareholders that want to participate in this extraordinary opportunity. This new issuance should be completed the week of the 14th keeping us within our target timeline."

About
Fortitude Group, Inc. is a diversified company with investments in multiple sectors of the economy targeting joint ventures, wholly owned subsidiaries and/or majority/minority positions that cross various market segments with the goal of creating a quality company that builds intrinsic value for its shareholders.

Forward Looking Statements
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.

Contact
Fortitude Group, Inc.
Investor Relations
Phone: 888-531-4931
Email: info@g3corp.net

Source: Marketwired (April 10, 2014 - 9:00 AM EDT)

News by QuoteMedia
www.quotemedia.com
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 38

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

The Synergy Company Celebrates Remarkable B Corp Recertification

Updated Category News Views 391

The Synergy Company Celebrates Remarkable B Corp Recertification The Synergy Company, renowned for its organic supplements, has achieved significant recognition by gaining recertification as a Certified B Corporation. This milestone comes with an impressive boost in its B Impact Assessment (BIA) score, rising from 93.8 to 111.3. This achievement is a true testament to the...

Continue Reading
Silicon Motion Sees Impressive Q3 Growth Amid Challenges

Updated Category News Views 132

Silicon Motion's Q3 2024 Earnings Review In the recently concluded third quarter of 2024, Silicon Motion Technology Corporation (NASDAQ: SIMO), a key competitor in the NAND flash controller market, experienced remarkable growth achieving a 60% increase in year-over-year revenue totaling $212.4 million. This surge was largely driven by their strategic partnerships and...

Continue Reading
Explore Insights from the Latest Banking Investor Conference

Updated Category News Views 212

Banking Virtual Investor Conference Highlights The recent Banking Virtual Investor Conference, a prominent series of online investor events, has provided a wealth of insights. Held earlier this month, the event showcased a selection of top-notch presentations from publicly traded banking companies eager to connect with investors. These presentations are now available for...

Continue Reading
XPO: A Leader in Innovation for Freight Transportation

Updated Category News Views 218

XPO Recognized for Innovation in Freight Transportation XPO (NYSE: XPO), a trailblazer in freight transportation across North America, has recently been acknowledged in Fortune’s prestigious list of America’s Most Innovative Companies. This accolade showcases XPO's commitment to providing top-tier services and technologies in an ever-evolving industry. CEO’s...

Continue Reading
Celebrating 35 Years of PALS Atlanta: Community and Pets Unite

Updated Category News Views 128

PALS Atlanta Celebrates 35 Years of Unwavering Community Support Pets Are Loving Support (PALS) cordially invites the community to partake in a momentous occasion celebrating 35 years of helping Atlantans living with critical illness keep their beloved pets at home. This remarkable milestone will feature a gala celebration, reflecting on the incredible work done over the...

Continue Reading